Lybrido(s)@home: a double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Acronyms @HOME; AT-HOME
- Sponsors Emotional Brain
- 15 Mar 2012 Actual end date changed from 12 Feb 2009 to 15 Oct 2009 as reported by European Clinical Trials Database.
- 22 Oct 2009 New trial record